UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oxaloacetate treatment preserves motor function in SOD1G93A mice and normalizes select neuroinflammation-related parameters in the spinal cord

Scientific reports, 2021-05, Vol.11 (1), p.11051-11051, Article 11051

2021

Volltextzugriff (PDF)

A novel physiologic marker of bulbar motor involvement in amyotrophic lateral sclerosis: Jaw muscle synergy

Clinical neurophysiology, 2021-01, Vol.132 (1), p.94-103

2021

Volltextzugriff (PDF)

Amyotrophic Lateral Sclerosis Regional Variants (Brachial Amyotrophic Diplegia, Leg Amyotrophic Diplegia, and Isolated Bulbar Amyotrophic Lateral Sclerosis)

Neurologic clinics, 2015-11, Vol.33 (4), p.775-785

2015

Volltextzugriff (PDF)

Using automated electronic medical record data extraction to model ALS survival and progression

BMC neurology, 2018-12, Vol.18 (1), p.205-205, Article 205

2018

Volltextzugriff (PDF)

Conducting a bayesian multi-armed trial with response adaptive randomization for comparative effectiveness of medications for CSPN

Contemporary clinical trials communications, 2023-12, Vol.36, p.101220-101220, Article 101220

2023

Volltextzugriff (PDF)

Ratio of Distal to Proximal Epidermal Nerve Fiber Density in Small Fiber Neuropathy (P1-11.006)

Neurology, 2024-04, Vol.102 (17_supplement_1)

2024

Volltextzugriff (PDF)

Inclusion Body Myositis: Phenotype and Antibody Testing Sensitivity (P1-11.019)

Neurology, 2024-04, Vol.102 (17_supplement_1)

2024

Volltextzugriff (PDF)

Real World Experience of New MG Therapies: Single Center Cohort Study (P7-8.012)

Neurology, 2023-04, Vol.100 (17_supplement_2)

2023

Volltextzugriff (PDF)

Mills’ Disease Variant (P3-8.012)

Neurology, 2023-04, Vol.100 (17_supplement_2)

2023

Volltextzugriff (PDF)

Pompe Disease

Neurologic clinics, 2014-08, Vol.32 (3), p.751-776

2014

Volltextzugriff (PDF)

Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS

Neurology, 2020-07, Vol.95 (1), p.e59

2020

Volltextzugriff (PDF)

Primary lateral sclerosis: consensus diagnostic criteria

Journal of neurology, neurosurgery and psychiatry, 2020-04, Vol.91 (4), p.373-377

2020

Volltextzugriff (PDF)

Neuromuscular complications of Immune checkpoint inhibitors. (3003)

Neurology, 2021-04, Vol.96 (15_supplement)

2021

Volltextzugriff (PDF)

Inclusion Body Myositis Treatment with Celution Processed Adipose Derived Regenerative Cells (P8-11.005)

Neurology, 2024-04, Vol.102 (17_supplement_1)

2024

Volltextzugriff (PDF)

Trial of Intravenous Immune Globulin in Dermatomyositis

The New England journal of medicine, 2022-10, Vol.387 (14), p.1264-1278

2022

Volltextzugriff (PDF)

Retrospective Review of Outcomes After Intervention for Enteral Nutrition in ALS Patients Enrolled in Midwest Multi-disciplinary ALS Clinics (P2-13.001)

Neurology, 2022-05, Vol.98 (18_supplement)

2022

Volltextzugriff (PDF)

COVID Spike antibodies in neuromuscular condition: KU experience (P11-13.005)

Neurology, 2022-05, Vol.98 (18_supplement)

2022

Volltextzugriff (PDF)

Neuropathy with Dysarthria and Ophthalmoparesis (P2.432)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

Subcutaneous Immunoglobulin (SCIG) Therapy for Neuromuscular Conditions; A KU Experience (2410)

Neurology, 2020-04, Vol.94 (15_supplement)

2020

Volltextzugriff (PDF)

Novel Pathogenic Variant in the SCN10A Gene Associated with Autosomal Dominant Small Fiber Neuropathy (2349)

Neurology, 2020-04, Vol.94 (15_supplement)

2020

Volltextzugriff (PDF)

Unusual Presentation of a Dystrophinopathy (2859)

Neurology, 2020-04, Vol.94 (15_supplement)

2020

Volltextzugriff (PDF)

Pseudomyasthenia Gravis: An uncommon and potentially hazardous mimicker of mitochondrial disease (5427)

Neurology, 2020-04, Vol.94 (15_supplement)

2020

Volltextzugriff (PDF)

FUS G559A Mutation in a Patient with a Frontotemporal Dementia-Motor Neuron Disease Compatible Syndrome: A Case Report

JAD reports, 2023-10, Vol.7 (1), p.1121-1126

2023

Volltextzugriff (PDF)

Non-dystrophic Myotonia: 2 year outcomes of objective and patient reported outcomes (2996)

Neurology, 2021-04, Vol.96 (15_supplement)

2021

Volltextzugriff (PDF)

Non‐dystrophic myotonia: 2‐year clinical and patient reported outcomes

Muscle & nerve, 2022-08, Vol.66 (2), p.148-158

2022

Volltextzugriff (PDF)

1 – 25 von 105

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(33)

Publikationsform

Sprache

Englisch
(105)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Oxaloacetate treatment preserves motor function in SOD1G93A mice and normalizes select neuroinflammation-related parameters in the spinal cord

A novel physiologic marker of bulbar motor involvement in amyotrophic lateral sclerosis: Jaw muscle synergy

Amyotrophic Lateral Sclerosis Regional Variants (Brachial Amyotrophic Diplegia, Leg Amyotrophic Diplegia, and Isolated Bulbar Amyotrophic Lateral Sclerosis)

Using automated electronic medical record data extraction to model ALS survival and progression

Conducting a bayesian multi-armed trial with response adaptive randomization for comparative effectiveness of medications for CSPN

Ratio of Distal to Proximal Epidermal Nerve Fiber Density in Small Fiber Neuropathy (P1-11.006)

Inclusion Body Myositis: Phenotype and Antibody Testing Sensitivity (P1-11.019)

Real World Experience of New MG Therapies: Single Center Cohort Study (P7-8.012)

Mills’ Disease Variant (P3-8.012)

Pompe Disease

Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS

Primary lateral sclerosis: consensus diagnostic criteria

Neuromuscular complications of Immune checkpoint inhibitors. (3003)

Inclusion Body Myositis Treatment with Celution Processed Adipose Derived Regenerative Cells (P8-11.005)

Trial of Intravenous Immune Globulin in Dermatomyositis

Retrospective Review of Outcomes After Intervention for Enteral Nutrition in ALS Patients Enrolled in Midwest Multi-disciplinary ALS Clinics (P2-13.001)

COVID Spike antibodies in neuromuscular condition: KU experience (P11-13.005)

Neuropathy with Dysarthria and Ophthalmoparesis (P2.432)

Subcutaneous Immunoglobulin (SCIG) Therapy for Neuromuscular Conditions; A KU Experience (2410)

Novel Pathogenic Variant in the SCN10A Gene Associated with Autosomal Dominant Small Fiber Neuropathy (2349)

Unusual Presentation of a Dystrophinopathy (2859)

Pseudomyasthenia Gravis: An uncommon and potentially hazardous mimicker of mitochondrial disease (5427)

FUS G559A Mutation in a Patient with a Frontotemporal Dementia-Motor Neuron Disease Compatible Syndrome: A Case Report

Non-dystrophic Myotonia: 2 year outcomes of objective and patient reported outcomes (2996)

Non‐dystrophic myotonia: 2‐year clinical and patient reported outcomes

Suchergebnisse filtern